dpp4 and glp 1 together DPP-4 inhibitors GLP-1RAs: cardiovascular safety and benefits | Military Medical Research Use of DPP-4 inhibitors and

Clin Exp Rheumatol (2021) 39(1):112

Cause irreversible denaturation of the cyclic peptide structure

Low circulating IGF-1 levels are associated with increased risk of insulin resistance, metabolic syndrome, and type 2 diabetes development

Verify the dose by checking the syringe markings carefully

Recommended starting dose: Discontinue other basal insulin and/or GLP-1 agonist before initiating Soliqua Patients naive to basal insulin or a GLP-1 agonist, currently on a GLP-1 agonist or less than 30 units of basal insulin daily: starting dose is 15 units once daily Patients currently on 30 to 60 units of basal insulin daily, with or without a GLP-1 agonist: starting dose is 30 units once daily Maintenance: titrate dose up or down by 2 - 4 units every week based on blood sugar goals Missed doses: resume dosing at the next scheduled dose

QUALITY FORMULATION - Developed to help reduce the appearance of wrinkles and improve skin texture